Fernando Ferrer
Affiliations: | Surgery | University of Connecticut Health Center, Farmington, CT, United States |
Google:
"Fernando Ferrer"Mean distance: 12.31 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ghosh M, Thangada S, Dasgupta O, et al. (2018) Cell-intrinsic sphingosine kinase 2 promotes macrophage polarization and renal inflammation in response to unilateral ureteral obstruction. Plos One. 13: e0194053 |
| Lockwood G, Ferrer F, Makari J. (2017) Bilateral Wilms Tumor with Ureteral Extension. Urology |
| Ehrlich PF, Hamilton TE, Gow K, et al. (2016) Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. Pediatric Blood & Cancer |
| Li MH, Swenson R, Harel M, et al. (2015) Antitumor activity of a novel S1P2 antagonist, AB1, in neuroblastoma. The Journal of Pharmacology and Experimental Therapeutics |
| Riemenschneider M, Makari JH, Rochon C, et al. (2015) Mass in failed renal allograft: Answers Pediatric Nephrology. 30: 443-444 |
| Li MH, Harel M, Hla T, et al. (2014) Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma. Journal of Pediatric Surgery. 49: 1286-91 |
| Ferrer F. (2014) Computerized tomography staging of renal tumors-does it make the surgeon obsolete? The Journal of Urology. 192: 6-7 |
| Thangada S, Shapiro LH, Silva C, et al. (2014) Treatment with the immunomodulator FTY720 (fingolimod) significantly reduces renal inflammation in murine unilateral ureteral obstruction. The Journal of Urology. 191: 1508-16 |
| Hamilton TE, Barnhart D, Gow K, et al. (2014) Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee study. Journal of Pediatric Surgery. 49: 154-8; discussion 15 |
| Li MH, Hla T, Ferrer F. (2013) FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway. Pediatric Blood & Cancer. 60: 1418-23 |